Global Payments Inc vs TransMedics Group Inc — how do they compare? Global Payments Inc trades at $80.34 (market cap $21.40B), while TransMedics Group Inc trades at $76.89 (market cap $2.61B). The key difference: Global Payments Inc is far larger — about 8.2× TransMedics Group Inc's market cap, and Global Payments Inc pays a 1.28% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| GPN | TMDX | |
|---|---|---|
Market Cap | $21.40B | $2.61B |
Sector | Industrials | Technology |
52-Week High | $90.01 | $150.42 |
52-Week Low | $62.47 | $61.99 |
Enterprise Value | $39.11B | $3.01B |
Dividend Yield | 1.28% | — |
Signals from Pluang's Aura AI — not financial advice
Global Payments (GPN) trades at $79.67, up 4.98% today, with a bullish technical outlook and strong earnings beats in recent quarters. The company shows robust operating cash flow of $2.66B in 2025 and benefits from strategic initiatives like the Worldpay integration and AI-powered POS expansions. However, net income margin turned negative at -7.97% for 2026, reflecting margin pressures amid rising costs and competitive fintech landscape.
GPN presents a mixed outlook: analyst consensus is bullish with a $81.56 price target (58% buy ratings), but investors face risks from debt growth (debt-to-asset ratio rising to 41.57% in 2025) and profitability challenges. Near-term catalysts include continued execution on commerce technology deals, while volatility may persist from macroeconomic headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →